Eosinophilia and progression to active tuberculosis in HIV-1-infected Ugandans

被引:21
|
作者
Elliott, AM
Kyosiimire, J
Quigley, MA
Nakiyingi, J
Watera, C
Brown, M
Joseph, S
French, N
Gilks, CF
Whitworth, JAG
机构
[1] Uganda Virus Res Inst, Entebbe, Uganda
[2] Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1E 7HT, England
[3] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England
[4] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England
[5] Univ London Imperial Coll Sci Technol & Med, Dept Med, London W2 1PG, England
基金
英国医学研究理事会; 英国惠康基金;
关键词
tuberculosis; HIV; eosinophilia; Uganda;
D O I
10.1016/S0035-9203(03)90096-4
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
It has been suggested that type 1 immune responses protect against tuberculosis (TB), while type 2 responses, such as those induced by helminths, may suppress protective responses and increase susceptibility to TB. Factors associated with progression to active TB were investigated in a cohort of HIV-1-infected Ugandan adults, a group at high risk of TB. High rates of subsequent progression to active TB were associated with eosinophil counts greater than or equal to 0.4 x 10(9)/L at enrolment. Eosinophilia at enrolment was associated with male gender, low socio-economic status, high CD4+ T cell counts, and schistosomiasis, but adjusting for these factors did not explain the association of eosinophilia with progression to active TB (adjusted rate ratio = 2.76, P = 0.004). Eosinophilia is most likely to be indicative of a type 2 immune response induced by helminth infection in this Ugandan cohort, but the mechanism of the observed association between eosinophilia and risk of TB remains to be determined.
引用
收藏
页码:477 / 480
页数:4
相关论文
共 50 条
  • [1] Cytokine responses and progression to active tuberculosis in HIV-1-infected Ugandans: a prospective study
    Elliott, AM
    Hodsdon, WS
    Kyosiimire, J
    Quigley, MA
    Nakiyingi, JS
    Namujju, PB
    Watera, C
    French, N
    Gilks, CF
    Dockrell, HM
    Whitworth, JAG
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2004, 98 (11) : 660 - 670
  • [2] The utility of screening for parasitic infections in HIV-1-infected Africans with eosinophilia in London
    Sarner, Liat
    Fakoya, Ade O.
    Tawana, Cheryl
    Allen, Elizabeth
    Copas, Andrew J.
    Chiodini, Peter L.
    Fenton, Kevin A.
    INTERNATIONAL JOURNAL OF STD & AIDS, 2007, 18 (09) : 626 - 629
  • [3] Predictors of incident tuberculosis among HIV-1-infected women in Tanzania
    Venkatesh, PA
    Bosch, RJ
    McIntosh, K
    Mugusi, E
    Msamanga, G
    Fawzi, WW
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2005, 9 (10) : 1105 - 1111
  • [4] Elevated Aspergillus-specific antibody levels among HIV infected Ugandans with pulmonary tuberculosis
    Kwizera, Richard
    Parkes-Ratanshi, Rosalind
    Page, Iain D.
    Sekaggya-Wiltshire, Christine
    Musaazi, Joseph
    Fehr, Jan
    Castelnuovo, Barbara
    Kambugu, Andrew
    Denning, David W.
    BMC PULMONARY MEDICINE, 2017, 17
  • [5] Elevated Aspergillus-specific antibody levels among HIV infected Ugandans with pulmonary tuberculosis
    Richard Kwizera
    Rosalind Parkes-Ratanshi
    Iain D. Page
    Christine Sekaggya-Wiltshire
    Joseph Musaazi
    Jan Fehr
    Barbara Castelnuovo
    Andrew Kambugu
    David W. Denning
    BMC Pulmonary Medicine, 17
  • [6] Association of prior tuberculosis with cardiovascular status in perinatally HIV-1-infected adolescents
    Magodoro, Itai M.
    Guerrero-Chalela, Carlos Eduardo
    Carkeek, Emma
    Asafu-Agyei, Nana Akua
    Jele, Nomawethu
    Frigati, Lisa J.
    Myer, Landon
    Jao, Jennifer
    Ntsekhe, Mpiko
    Wilkinson, Katalin A.
    Wilkinson, Robert J.
    Zar, Heather
    Ntusi, Ntobeko
    OPEN HEART, 2024, 11 (02):
  • [7] Evaluation of super-boosted lopinavir/ritonavir in combination with rifampicin in HIV-1-infected patients with tuberculosis
    Boulanger, Catherine
    Rolla, Valeria
    Al-Shaer, Mohammad H.
    Peloquin, Charles
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2020, 55 (02)
  • [8] Inhibition of human immunodeficiency virus-1 (HIV-1) by β-chemokine analogues in mononuclear cells from HIV-1-infected patients with active tuberculosis
    Toossi, Z
    Mayanja-Kizza, H
    Baseke, J
    Peters, P
    Wu, M
    Abraha, A
    Aung, H
    Okwera, A
    Hirsch, C
    Arts, E
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2005, 142 (02) : 327 - 332
  • [9] Greater diversity of HIV-1 quasispecies in HIV-infected individuals with active tuberculosis
    Collins, KR
    Mayanja-Kizza, H
    Sullivan, BA
    Quiñones-Mateu, ME
    Toossi, Z
    Arts, EJ
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2000, 24 (05) : 408 - 417
  • [10] Immunopathology as a result of highly active antiretroviral therapy in HIV-1-infected patients
    Foudraine, NA
    Hovenkamp, E
    Notermans, DW
    Meenhorst, PL
    Klein, MR
    Lange, JMA
    Miedema, F
    Reiss, P
    AIDS, 1999, 13 (02) : 177 - 184